What is the current valuation of the US stem cell-banking market as of 2024?

The US stem cell-banking market was valued at $1890.0 Million in 2024. Read More

What is the projected market valuation for the US stem cell-banking market in 2035?

The projected valuation for the US stem cell-banking market in 2035 is $5800.0 Million. Read More

What is the expected CAGR for the US stem cell-banking market during the forecast period 2025 - 2035?

The expected CAGR for the US stem cell-banking market during the forecast period 2025 - 2035 is 10.73%. Read More

Which segment of stem cell sources had the highest valuation in 2024?

In 2024, the Umbilical Cord Blood segment had the highest valuation at $600.0 Million. Read More

What are the projected valuations for Adult Stem Cells by 2035?

The projected valuation for Adult Stem Cells is expected to reach $2200.0 Million by 2035. Read More

Which type of stem cells is anticipated to show significant growth in the coming years?

Hematopoietic Stem Cells are anticipated to show significant growth, with a projected valuation of $1800.0 Million by 2035. Read More

What was the valuation of cryopreservation in the US stem cell-banking market in 2024?

Cryopreservation was valued at $900.0 Million in 2024. Read More

How do biotechnology companies contribute to the US stem cell-banking market?

Biotechnology companies are projected to contribute $1800.0 Million to the US stem cell-banking market by 2035. Read More

What is the expected valuation for tissue preservation in the US stem cell-banking market by 2035?

The expected valuation for tissue preservation is projected to be $1200.0 Million by 2035. Read More

Which key players are leading the US stem cell-banking market?

Key players in the US stem cell-banking market include Cord Blood Registry, Viacord, and Cryo-Cell International. Read More

US Stem Cell Banking Market

ID: MRFR/LS/13088-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Stem Cell Banking Market Research Report: Size, Share, Trend Analysis By Cell Type (Umbilical Cord Stem Cells, Adult Stem Cells, Embryonic Stem Cells), By Bank Type (Private Banks, Public Banks, Hybrid Banks) and By Applications (Thalassemia, Cerebral Palsy, Diabetes, Leukemia, Autism) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Stem Cell Source (USD Million)
  1. 4.1.1 Umbilical Cord Blood
  2. 4.1.2 Adult Stem Cells
  3. 4.1.3 Embryonic Stem Cells
  4. 4.1.4 Perinatal Stem Cells
2. 4.2 Security, Access Control and Robotics, BY Cell Type (USD Million)
  1. 4.2.1 Hematopoietic Stem Cells
  2. 4.2.2 Mesenchymal Stem Cells
  3. 4.2.3 Neural Stem Cells
  4. 4.2.4 Induced Pluripotent Stem Cells
3. 4.3 Security, Access Control and Robotics, BY Storage Type (USD Million)
  1. 4.3.1 Cryopreservation
  2. 4.3.2 Stem Cell Culture
  3. 4.3.3 Tissue Preservation
4. 4.4 Security, Access Control and Robotics, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Institutions
  3. 4.4.3 Biotechnology Companies
  4. 4.4.4 Pharmaceutical Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Cord Blood Registry (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Viacord (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cryo-Cell International (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 LifebankUSA (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 StemCyte (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cells4Life (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cryo-Save (NL)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Smart Cells (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY STEM CELL SOURCE
3. 6.3 US MARKET ANALYSIS BY CELL TYPE
4. 6.4 US MARKET ANALYSIS BY STORAGE TYPE
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY STEM CELL SOURCE, 2024 (% SHARE)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY STEM CELL SOURCE, 2024 TO 2035 (USD Million)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY CELL TYPE, 2024 (% SHARE)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY CELL TYPE, 2024 TO 2035 (USD Million)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY STORAGE TYPE, 2024 (% SHARE)
17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY STORAGE TYPE, 2024 TO 2035 (USD Million)
18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END USER, 2024 (% SHARE)
19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY STEM CELL SOURCE, 2025-2035 (USD Million)
  2. 7.2.2 BY CELL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY STORAGE TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Stem Cell Source (USD Million, 2025-2035)

Umbilical Cord Blood
Adult Stem Cells
Embryonic Stem Cells
Perinatal Stem Cells

Security, Access Control and Robotics By Cell Type (USD Million, 2025-2035)

Hematopoietic Stem Cells
Mesenchymal Stem Cells
Neural Stem Cells
Induced Pluripotent Stem Cells

Security, Access Control and Robotics By Storage Type (USD Million, 2025-2035)

Cryopreservation
Stem Cell Culture
Tissue Preservation

Security, Access Control and Robotics By End User (USD Million, 2025-2035)

Hospitals
Research Institutions
Biotechnology Companies
Pharmaceutical Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”